A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Titel:
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Auteur:
Hayer, Manvir K. Edwards, Nicola C. Slinn, Gemma Moody, William E. Steeds, Rick P. Ferro, Charles J. Price, Anna M. Andujar, Cecilio Dutton, Mary Webster, Rachel Webb, David J. Semple, Scott MacIntyre, Iain Melville, Vanessa Wilkinson, Ian B. Hiemstra, Thomas F. Wheeler, David C. Herrey, Anna Grant, Margaret Mehta, Samir Ives, Natalie Townend, Jonathan N.